SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

74,781.76 -120.83
( -0.16%)

Global Indices

Nasdaq

52,596.82 511.72
(0.98%)

Dow Jones

7,678.62 65.92
(0.87%)

Hang Seng

63,517.44 -493.90
(-0.77%)

Nikkei 225

10,692.77 42.33
(0.40%)

Forex

USD-INR

95.45 0.39
(0.41%)

EUR-INR

110.95 0.35
(0.32%)

GBP-INR

129.16 0.36
(0.28%)

JPY-INR

0.62 0.00
(0.09%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Remus Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

78788

INE0O5T01011

276.4035981

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

REMUS

41.96

1036.99

EPS(TTM)

Face Value()

Div & Yield %

20.97

0.06

Back

Regent Enterprises standalone net profit rises 54.27% in the June 2026 quarter

Aug 13,2026

Net profit of Regent Enterprises rose 54.27% to Rs 2.53 crore in the quarter ended June 2026 as against Rs 1.64 crore during the previous quarter ended June 2025. Sales declined 42.07% to Rs 138.27 crore in the quarter ended June 2026 as against Rs 238.67 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	138.27	238.67	-42
OPM %	1.27	0.74	-
PBDT	1.76	1.77	-1
PBT	1.63	1.64	-1
NP	2.53	1.64	54

74,781.76 -120.83 ( -0.16%)

52,596.82 511.72 (0.98%)

7,678.62 65.92 (0.87%)

63,517.44 -493.90 (-0.77%)

10,692.77 42.33 (0.40%)

95.45 0.39 (0.41%)

110.95 0.35 (0.32%)

129.16 0.36 (0.28%)

0.62 0.00 (0.09%)